Testing effectiveness (Phase 2)Study completedNCT01323400What this trial is testingEfficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)Who this might be right forGIST Centre Leon Berard 81
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Study completedNCT04995419What this trial is testingEvaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor TherapyWho this might be right forMetastatic Urothelial Cancer Astellas Pharma China, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT00210028What this trial is testingStudy Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerWho this might be right forBreast Neoplasms Institut Claudius Regaud 40
Not applicableStudy completedNCT05396807What this trial is testingREVERT - taRgeted thErapy for adVanced colorEctal canceR paTientsWho this might be right forMetastatic Colon Cancer University of Rome Tor Vergata 106
Very early researchActive Not RecruitingNCT05488366What this trial is testingImmunotherapy Combined With Radiotherapy for Metastatic SarcomaWho this might be right forSarcoma, Soft Tissue University of California, Irvine 9
Early research (Phase 1)Study completedNCT02138929What this trial is testingLDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaWho this might be right forEsophageal Cancer M.D. Anderson Cancer Center 25
Large-scale testing (Phase 3)Looking for participantsNCT06658353What this trial is testingPhase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid TumorsWho this might be right forLocally Advanced Solid Tumor Jiangsu vcare pharmaceutical technology co., LTD 54
Not applicableStudy completedNCT01445145What this trial is testingAn Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV InfectionWho this might be right forNeoplasms National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00416767What this trial is testingCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Early research (Phase 1)Study completedNCT02959905What this trial is testingTreatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)Who this might be right forSolid Cancer BGI, China 11
Testing effectiveness (Phase 2)Looking for participantsNCT06342037What this trial is testingNOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 TrialWho this might be right forMetastatic Breast Cancer The Netherlands Cancer Institute 60
Large-scale testing (Phase 3)Looking for participantsNCT07071337What this trial is testingSKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine TherapyWho this might be right forMetastatic Breast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT04278781What this trial is testingAG-120 in People With IDH1 Mutant ChondrosarcomaWho this might be right forChondrosarcomaChondrosarcoma, Grade 2Chondrosarcoma, Grade 3+1 more Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01210911What this trial is testingMetformin Combined With Chemotherapy for Pancreatic CancerWho this might be right forLocally Advanced Pancreatic CancerMetastatic Pancreatic Cancer Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Testing effectiveness (Phase 2)Study completedNCT00068211What this trial is testingStudy of ILX651 in Patients With Inoperable Locally Advanced or Metastatic MelanomaWho this might be right forMelanoma Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT05075564What this trial is testingES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumor Elpiscience Biopharma, Ltd. 8
Testing effectiveness (Phase 2)Looking for participantsNCT02029001What this trial is testingAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentWho this might be right forMalignant Solid Neoplasms Centre Leon Berard 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT04919811What this trial is testingTaletrectinib Phase 2 Global Study in ROS1 Positive NSCLCWho this might be right forNon Small Cell Lung Cancer Nuvation Bio Inc. 217